We are live on ! Find out more
HFCIV

H&F Corporate Investors VIII Portfolio holdings

AUM $133M Turnover 0%
1-Year Est. Return 24.42%
This Fund
S&P 500
This Quarter Est. Return
+108.75%
1 Year Est. Return
-24.42%
3 Year Est. Return
-33.78%
5 Year Est. Return
-50.35%
10 Year Est. Return
–
AUM
$133M
AUM Growth
+$69.1M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
1
New
–
Increased
–
Reduced
–
Closed
–
Avg Time Held
5.5 years
Top 10 Avg Time Held
5.5 years
Top 20 Avg Time Held
5.5 years

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
CTEV icon
1
Claritev Corp
CTEV
$404M
$133M 100%
3,887,858
– –
2020 Q4
22 quarters

Similar funds

H&F Corporate Investors VIII's Q2 2026 Portfolio in Review

As of Q2 2026, H&F Corporate Investors VIII held 1 position worth $133M, up 109% from $63.5M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q2 2026: portfolio turnover was 0%. H&F Corporate Investors VIII opened no new positions and made no exits, leaving the 1-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • H&F Corporate Investors VIII's ten largest holdings make up 100% of its $133M portfolio in Q2 2026.
  • H&F Corporate Investors VIII opened 0 new positions and closed 0 in Q2 2026.
  • H&F Corporate Investors VIII's portfolio value rose 109% quarter-over-quarter to $133M.

Based on H&F Corporate Investors VIII's 13F filing for Q2 2026, filed 12 Aug 2026.